Corcept Therapeutics
Lucas Buxman possesses a diverse background in the pharmaceutical and healthcare sectors, with significant experience in commercial insights and analytics. Currently serving as the Director of Commercial Insights and Analytics at Corcept Therapeutics, Lucas has previously held leadership roles, including Sr Director and Practice Lead for Rare Disease and Director of Customer Success at Claritas Rx. Additionally, Lucas gained experience in investment and management within the real estate and property management sector. Previous roles at Genentech BioOncology included Group Product Manager for Avastin in breast cancer and Group Product Manager for dermatology at Genentech/Roche.
This person is not in any teams
Corcept Therapeutics
4 followers
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.